News and Events
Upcoming Events
March 16, 2026
March 26 ICOC/ARS Meeting
March 10, 2026
March 19 Science Subcommittee Meeting
March 5, 2026
March 19-20 Grants Working Group Meeting
February 27, 2026
March 9 Governance Subcommittee Meeting
Latest Press Releases
January 29, 2026
CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases
December 11, 2025
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
October 30, 2025
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
CIRM’s Blog: The Stem Cellar
The Stem Cellar
- CIRM-funded clinical trial gives siblings a second chance at life March 17, 2026written by Holly Alyssa MacCormick Alicia Langenhop was seven months pregnant with her third child when she and her husband, Jon, learned that their two toddlers had a life-threatening immune disease called leukocyte adhesion deficiency-1 (LAD-1). The odds of being born with LAD-1 are rare, literally one-in-a-million, but the disease is genetic, so the Langenhop’s unborn child had a roughly 25 percent chance of having the disease. […]
- Closer to Cures: Stanford researcher Crystal Mackall discusses progress on clinical trials for rare cancers of the brain and spine with no known cure. March 6, 2026Written by Holly Alyssa MacCormick In 2023, the California Institute for Regenerative Medicine (CIRM) funded a clinical trial led by Stanford researcher Crystal Mackall, MD, to investigate a possible therapy for rare brain and spinal tumors that arise from a specific genetic mutation, known as H3K27M. These cancers are devastating. Each year, about 1,000 people […]
- Closer to Cures: Cory R. Nicholas, CEO and co-founder of Neurona Therapeutics, discusses progress in clinical trials for patients with epilepsy that does not respond to drugs. February 26, 2026Written by Holly Alyssa MacCormick Roughly 3 million adults living in the United States have epilepsy, and about 400,000 of these people live in California, according to the CDC. Of these people, about one-third to half continue to have seizures that do not respond to medications on the market. It’s those patients who don’t respond to medications that Neurona Therapeutics is hoping to help with a stem-cell derived approach currently in clinical trials. […]